Cargando…
Development and Characterization of Potent Succinate Receptor Fluorescent Tracers
[Image: see text] The succinate receptor (SUCNR1) has emerged as a potential target for the treatment of various metabolic and inflammatory diseases, including hypertension, inflammatory bowel disease, and rheumatoid arthritis. While several ligands for this receptor have been reported, species diff...
Autores principales: | Ciba, Marija, Dibnah, Bethany, Hudson, Brian D., Rexen Ulven, Elisabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350927/ https://www.ncbi.nlm.nih.gov/pubmed/37318348 http://dx.doi.org/10.1021/acs.jmedchem.3c00552 |
Ejemplares similares
-
Receptor structure-based discovery of non-metabolite agonists for the succinate receptor GPR91
por: Trauelsen, Mette, et al.
Publicado: (2017) -
Structure-Activity Investigations and Optimisations of Non-metabolite Agonists for the Succinate Receptor 1
por: Rexen Ulven, Elisabeth, et al.
Publicado: (2018) -
Discovery of Potent
Tetrazole Free Fatty Acid Receptor
2 Antagonists
por: Valentini, Alice, et al.
Publicado: (2023) -
Chemogenetics defines a short-chain fatty acid receptor gut–brain axis
por: Barki, Natasja, et al.
Publicado: (2022) -
Ligand entry pathways control the chemical space recognized by GPR183
por: Kjær, Viktoria Madeline Skovgaard, et al.
Publicado: (2023)